MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
  Publication Details

   Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2017
Product type:
   Statistical Brief 529
MEPS component:
   Household Component
Publication date:
   April 24, 2020
   In 2017, total outpatient prescription opioid expenses for adults totaled $7.7 billion with Hydrocodone and Oxycodone accounting for nearly three-quarters of those expenses. This Statistical Brief presents Medical Expenditure Panel Survey (MEPS) Household Component (HC) estimates of total expenses and prescription fills for all outpatient prescription opioids that are commonly used to treat pain, and the top five opioid products ranked by total expenses in 2017: hydrocodone, oxycodone, tramadol, morphine, and codeine. The distribution of spending by source of payment is compared for all outpatient prescription medications, outpatient prescription opioids, as well as across four opioid products. In addition, annual total and out-of-pocket expense per person were estimated for all outpatient prescriptions among adults with at least one outpatient opioid fill and at least one fill of the top five opioid products in 2017.
   Yao Ding, PhD; and G. Edward Miller, PhD
   Rockville (MD): Agency for Healthcare Research and Quality
   Web Only
MEPS Topics:
   Prescribed Drug Use/Events and Expenditures , Prescription Drugs
PDF link:
   data_files/publications/st529/stat529.pdf (552 KB)
HTML link:
  Back to search results   Printing tips   Notes on viewing and downloading files  

Back to topGo back to top
Get Social
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364
Improving the Quality, Safety, Efficiency, and Effectiveness of Health Care For All Americans